Browsing Category
Pharma Industry News
4753 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Aarti Drugs faces revenue decline amid API Market challenges in Q3 FY25
Aarti Drugs Limited, a Mumbai-based pharmaceutical company engaged in Active Pharmaceutical Ingredients (API), formulations, specialty chemicals, and intermediates,…
Amgen’s Blincyto gains EU approval for consolidation phase treatment in B-ALL
Amgen has received European Commission approval for Blincyto (blinatumomab) as part of consolidation therapy in adults with newly…
ImmunityBio, BeiGene launch Phase 3 Trial to advance lung cancer immunotherapy
ImmunityBio, Inc. (NASDAQ: IBRX) has entered into a collaboration and supply agreement with BeiGene, Ltd., a global oncology…
TME Pharma expands AI-driven drug discovery with Aimed Analytics partnership
TME Pharma, a biotechnology company pioneering therapies that target the tumor microenvironment, has announced a strategic collaboration with…
OneSource Specialty Pharma reports stellar Q3FY25 earnings with 85% EBITDA growth, setting stage for expansion
OneSource Specialty Pharma Limited, formerly Stelis Biopharma Limited, has delivered a strong financial performance in its first full…
Conduit Pharmaceuticals sets the bar with AI in drug development and autoimmune therapies
Conduit Pharmaceuticals Inc. (Nasdaq: CDT), a clinical-stage life sciences company, is making waves in the pharmaceutical industry by…
Silexion Therapeutics’ SIL-204 shows potential to transform pancreatic cancer treatment
Silexion Therapeutics Corp. (NASDAQ: SLXN), a clinical-stage biotechnology company specializing in RNA interference (RNAi) therapies, has reported promising…
MediSpend acquires Real Life Sciences to bolster governance and compliance solutions
MediSpend, a global leader in technology solutions for the life sciences industry, has taken a significant step in…
ENHERTU gains FDA approval for HER2 low or ultralow metastatic breast cancer treatment
Daiichi Sankyo and AstraZeneca’s ENHERTU (fam-trastuzumab deruxtecan-nxki) has secured approval from the U.S. Food and Drug Administration (FDA)…
FDA approves Leqembi maintenance dosing for early Alzheimer’s treatment
The U.S. Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi (lecanemab-irmb), an…